poisar

Stocks · News reference

Evogene Q2 EPS $(0.63) Misses $(0.27) Estimate, Sales $347.000K Beat $325.000K Estimate

BenzingaAug 18, 2026, 11:04 AMBenzinga Newsdesk

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.27) by 133.33 percent. This is a 26 percent decrease over losses of $(0.50) per share from the same

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 18, 2026, 11:04 AM
Checked
Aug 18, 2026, 11:04 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading